Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease.
OBJECTIVE
While the literature supports the use of radiation therapy for thyroid eye disease, it does not sufficiently describe in detail the results of radiation therapy for optic neuropathy associated with thyroid eye disease. The objective of this study is to quantify the changes in parameters of optic neuropathy after orbital irradiation for thyroid eye disease.


METHODS
Twelve consecutive patients with optic neuropathy from thyroid eye disease were followed by a single neuro-ophthalmology practice and treated by one radiation oncologist with radiation therapy from 1991 through 1995. All cases were prospectively followed for visual acuity, color vision, mean deviation, and/or foveal sensitivity and afferent pupillary defect. All patients received 2000 cGy in 10 fractions with megavoltage irradiation to the orbits.


RESULTS
Ten of 12 patients were evaluated for follow-up (one moved out of this country and one had a stroke, which confounded interpretation of examination results). An analysis was performed retrospectively while treatment and evaluation remained uniform. Five men and five women formed the basis of this study with a median age of 60 years (35-76 years). Nineteen eyes were evaluated for thyroid optic neuropathy. Improvement in optic nerve function occurred in eight of ten patients. Improvement was seen either during radiotherapy or within 2 weeks of completion. No long-term adverse effects were noted.


CONCLUSIONS
This study objectively demonstrates improvement in optic neuropathy from radiation therapy for thyroid eye disease.
Rush
S
S
Long Island Radiation Therapy, Manhasset, NY, USA.
Winterkorn
J M
JM
Zak
R
R
D000328:Adult; D000368:Aged; D003118:Color Perception / Q000502:physiology / Q000528:radiation effects*; D005260:Female; D006111:Graves Disease / Q000209:etiology / Q000503:physiopathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009901:Optic Nerve Diseases / Q000209:etiology / Q000503:physiopathology / Q000532:radiotherapy*; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D014792:Visual Acuity / Q000502:physiology / Q000528:radiation effects*